Inicio › Cáncer metastásico › California › Mountain View
Ensayos clínicos de Cáncer metastásico en Mountain View, CA
25 estudios para Cáncer metastásico buscan participantes en centros de Mountain View y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
ReclutandoFase 2
- Stanford Cancer Institute Palo Alto, Palo Alto · A 5 mi de distancia
- VA Palo Alto Health Care System, Palo Alto · A 5 mi de distancia
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
ReclutandoFase 1/2
- Stanford, Palo Alto · A 5 mi de distancia
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
ReclutandoFase 2/3
- Stanford Cancer Center, Palo Alto · A 5 mi de distancia
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
ReclutandoFase 3
- Palo Alto Medical Foundation - Palo Alto Center, Palo Alto · A 5 mi de distancia
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
ReclutandoFase 1/2
- Stanford Medicine, Palo Alto · A 5 mi de distancia
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
ReclutandoFase 1
- Stanford Cancer Institute, Stanford · A 5 mi de distancia
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
ReclutandoFase 1
- Stanford University Medical Center, Stanford · A 5 mi de distancia
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
ReclutandoFase 3
- Stanford Women's Cancer Center, Palo Alto · A 5 mi de distancia
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
ReclutandoFase 3
- Stanford Cancer Center, Palo Alto · A 5 mi de distancia
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
ReclutandoFase 1/2
- Stanford Cancer Institute, Stanford · A 5 mi de distancia
Trial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases.
ReclutandoFase 2
- Stanford University, Palo Alto · A 5 mi de distancia
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
ReclutandoFase 3
- Research Site, Palo Alto · A 5 mi de distancia
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
ReclutandoFase 1/2
- Stanford Cancer Institute (SCI), Stanford · A 5 mi de distancia
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
ReclutandoFase 1
- Stanford Medicine Cancer Center, Stanford · A 5 mi de distancia
FOG-001 in Locally Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- Stanford Cancer Institute, Stanford University, Palo Alto · A 5 mi de distancia
Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases
ReclutandoFase 3
- Stanford University School of Medicine, Palo Alto · A 5 mi de distancia
A Study of LY4175408 in Participants With Advanced Cancer
ReclutandoFase 1
- Stanford Medicine Cancer Center, Stanford · A 5 mi de distancia
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
ReclutandoFase 1/2
- Stanford Cancer Institute, Stanford · A 5 mi de distancia
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
ReclutandoFase 2/3
- Stanford Health Care - Skin Cancer Program, Stanford · A 5 mi de distancia
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
ReclutandoFase 2/3
- Stanford Cancer Institute, Palo Alto · A 5 mi de distancia
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
ReclutandoFase 1
- Stanford Cancer Institute, Stanford · A 5 mi de distancia
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
ReclutandoFase 1
- Stanford Cancer Institute, Stanford · A 5 mi de distancia
Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
ReclutandoEstudio observacional
- VA Palo Alto Healthcare System, Palo Alto · A 5 mi de distancia
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
ReclutandoFase 1
- Stanford Cancer Institute, Palo Alto · A 5 mi de distancia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Stanford · A 5 mi de distancia
Ensayos de Cáncer metastásico en otras ciudades
- Houston, TX104 estudios
- New York City, NY93 estudios
- Nashville, TN70 estudios
- Boston, MA63 estudios
- Los Angeles, CA57 estudios
- St. Louis, MO54 estudios
- Arlington, VA53 estudios
- Philadelphia, PA46 estudios
- Chicago, IL45 estudios
- San Antonio, TX44 estudios
- Washington, DC43 estudios
- Dallas, TX42 estudios
Otros estudios en Mountain View
- Cáncer (todos los tipos)40 estudios
- Cáncer de seno26 estudios
- Cáncer de pulmón de células no pequeñas21 estudios
- Leucemia mielógena aguda19 estudios
- Cáncer de ovario19 estudios
- Trastorno del espectro autista17 estudios
- Cáncer de pulmón17 estudios
- Cáncer de próstata15 estudios
- Fallo cardíaco15 estudios
- Autismo13 estudios
- Leucemia linfoblástica aguda13 estudios
- Cáncer del colon y del recto13 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.